366 participants
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-22
- Start Date:
- 2020-10-01
- Completion:
- 2022-09-28
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG